Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced gastric or gastroesophageal junction cancer from JAVELIN solid tumor phase Ib trial: Analysis of safety and clinical activity - Chung HC, A.H., Wyrwicz L et al (J Clin Oncol, 2016)